Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3397191 | Clinical Microbiology and Infection | 2012 | 4 Pages |
Abstract
The clinical characteristics and risk factors for 28-day mortality in 120 patients with solid tumours with Acinetobacter nosocomialis bacteraemia were retrospectively analysed. Eighty-one patients (67.5%) had advanced-stage cancer. Most of the bacteraemia (37.5%) did not have an identified source. The bacteraemia episodes developed at a median of 15 days after hospitalization, and most during a non-neutropenic period (97.5%). Although only half of the patients received appropriate antimicrobial therapy, the mortality was relatively low (11.7%). High Pitt bacteraemia score and receipt of chemotherapy within the month before bacteraemia onset were independently associated with 28-day mortality.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
Hau-Shin Wu, Shu-Chen Kuo, Yi-Tzu Lee, Ya-Sung Yang, Shu-Shing Cheng, Te-Li Chen, Chang-Phone Fung,